Prostate Cancer Foundation shared on X:
“Not all high-risk prostate cancer is the same! Shared decision-making and personalized treatment approaches are crucial for patient outcomes. Genomic tests like Decipher help distinguish risk levels.
Rana McKay, Leslie Ballas discuss on UroToday.com”
